Insulet ROE 2010-2025 | PODD
Current and historical return on equity (ROE) values for Insulet (PODD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Insulet ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $0.24B | $1.46B | 18.50% |
| 2025-03-31 | $0.40B | $1.33B | 34.60% |
| 2024-12-31 | $0.42B | $1.21B | 40.79% |
| 2024-09-30 | $0.42B | $1.12B | 46.37% |
| 2024-06-30 | $0.40B | $1.00B | 50.61% |
| 2024-03-31 | $0.23B | $0.79B | 34.85% |
| 2023-12-31 | $0.21B | $0.73B | 34.36% |
| 2023-09-30 | $0.12B | $0.61B | 22.42% |
| 2023-06-30 | $0.06B | $0.55B | 12.85% |
| 2023-03-31 | $0.00B | $0.50B | 0.22% |
| 2022-12-31 | $0.00B | $0.48B | 1.13% |
| 2022-09-30 | $0.02B | $0.43B | 3.67% |
| 2022-06-30 | $0.04B | $0.42B | 7.28% |
| 2022-03-31 | $0.05B | $0.45B | 9.18% |
| 2021-09-30 | $-0.03B | $0.50B | -5.41% |
| 2021-06-30 | $-0.03B | $0.46B | -5.35% |
| 2020-12-31 | $0.01B | $0.60B | 1.54% |
| 2020-09-30 | $0.03B | $0.60B | 8.97% |
| 2020-06-30 | $0.02B | $0.56B | 8.48% |
| 2020-03-31 | $0.01B | $0.06B | 3.73% |
| 2019-12-31 | $0.01B | $0.08B | 6.28% |
| 2019-09-30 | $0.02B | $0.15B | 7.65% |
| 2019-06-30 | $0.02B | $0.25B | 7.69% |
| 2019-03-31 | $0.01B | $0.22B | 6.89% |
| 2018-12-31 | $0.00B | $0.21B | 1.58% |
| 2018-09-30 | $-0.01B | $0.20B | -7.92% |
| 2018-06-30 | $-0.02B | $0.18B | -12.35% |
| 2018-03-31 | $-0.02B | $0.17B | -20.47% |
| 2017-12-31 | $-0.03B | $0.16B | -29.83% |
| 2017-09-30 | $-0.03B | $0.07B | -43.61% |
| 2017-06-30 | $-0.03B | $0.07B | -46.69% |
| 2017-03-31 | $-0.03B | $0.06B | -47.49% |
| 2016-12-31 | $-0.03B | $0.06B | -61.88% |
| 2016-09-30 | $-0.05B | $0.07B | -121.05% |
| 2016-06-30 | $-0.06B | $0.03B | -174.65% |
| 2016-03-31 | $-0.07B | $0.03B | -157.84% |
| 2015-12-31 | $-0.07B | $0.03B | -121.67% |
| 2015-09-30 | $-0.05B | $0.06B | -70.34% |
| 2015-06-30 | $-0.04B | $0.07B | -54.60% |
| 2015-03-31 | $-0.06B | $0.08B | -70.59% |
| 2014-12-31 | $-0.05B | $0.08B | -56.04% |
| 2014-09-30 | $-0.05B | $0.08B | -48.40% |
| 2014-06-30 | $-0.06B | $0.08B | -52.91% |
| 2014-03-31 | $-0.04B | $0.12B | -32.41% |
| 2013-12-31 | $-0.05B | $0.13B | -35.80% |
| 2013-09-30 | $-0.05B | $0.12B | -48.96% |
| 2013-06-30 | $-0.04B | $0.14B | -48.62% |
| 2013-03-31 | $-0.05B | $0.13B | -66.43% |
| 2012-12-31 | $-0.05B | $0.04B | -91.48% |
| 2012-09-30 | $-0.06B | $0.05B | -83.97% |
| 2012-06-30 | $-0.06B | $0.06B | -77.29% |
| 2012-03-31 | $-0.05B | $0.07B | -61.82% |
| 2011-12-31 | $-0.05B | $0.08B | -57.50% |
| 2011-09-30 | $-0.05B | $0.08B | -69.97% |
| 2011-06-30 | $-0.05B | $0.09B | -80.31% |
| 2011-03-31 | $-0.06B | $0.06B | -111.76% |
| 2010-12-31 | $-0.06B | $0.07B | -131.89% |
| 2010-09-30 | $-0.06B | $0.03B | -123.76% |
| 2010-06-30 | $-0.06B | $0.04B | -165.99% |
| 2010-03-31 | $-0.07B | $0.04B | -268.00% |
| 2009-12-31 | $-0.07B | $0.06B | -394.59% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $23.765B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.644B | 26.81 |
| Boston Scientific (BSX) | United States | $156.695B | 37.37 |
| Stryker (SYK) | United States | $148.974B | 30.33 |
| EssilorLuxottica (ESLOY) | France | $142.491B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.926B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.457B | 24.85 |
| ResMed (RMD) | United States | $40.320B | 28.84 |
| Agilent Technologies (A) | United States | $35.497B | 22.93 |
| GE HealthCare Technologies (GEHC) | United States | $33.658B | 15.82 |
| Terumo (TRUMY) | Japan | $26.798B | 31.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.812B | 13.25 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.306B | 0.00 |
| Baxter (BAX) | United States | $12.532B | 9.68 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.947B | 29.19 |
| Lantheus Holdings (LNTH) | United States | $3.774B | 10.20 |
| Envista Holdings (NVST) | United States | $3.531B | 24.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.310B | 14.69 |
| Perrigo (PRGO) | Ireland | $3.269B | 8.16 |
| ICU Medical (ICUI) | United States | $3.136B | 21.35 |
| Haemonetics (HAE) | United States | $2.618B | 11.69 |
| Curaleaf Holdings (CURLF) | Canada | $2.259B | 0.00 |
| Acuren (TIC) | United States | $2.215B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| QuidelOrtho (QDEL) | United States | $1.901B | 11.97 |
| Green Thumb Industries (GTBIF) | United States | $1.865B | 80.09 |
| AtriCure (ATRC) | United States | $1.850B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.618B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.559B | 18.40 |
| AdaptHealth (AHCO) | United States | $1.250B | 17.77 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.194B | 2492.00 |
| InMode (INMD) | Israel | $0.943B | 8.73 |
| Kestra Medical Technologies (KMTS) | United States | $0.909B | 0.00 |
| Valneva SE (VALN) | France | $0.752B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.727B | 0.00 |
| SNDL (SNDL) | Canada | $0.707B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.608B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.597B | 0.00 |
| ZimVie (ZIMV) | United States | $0.533B | 20.54 |
| Surmodics (SRDX) | United States | $0.491B | 0.00 |
| Evolus (EOLS) | United States | $0.486B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.476B | 16.39 |
| Canopy Growth (CGC) | Canada | $0.451B | 0.00 |
| CeriBell (CBLL) | United States | $0.439B | 0.00 |
| Owens & Minor (OMI) | United States | $0.383B | 3.40 |
| Sanuwave Health (SNWV) | United States | $0.364B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.343B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.317B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 21.26 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Exagen (XGN) | United States | $0.214B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.59 |
| FitLife Brands (FTLF) | United States | $0.175B | 21.60 |
| Biote (BTMD) | United States | $0.172B | 5.69 |
| Jushi Holdings (JUSHF) | United States | $0.147B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.70 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.21 |
| MariMed (MRMD) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.58 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.34 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Sharps Technology (STSS) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |